Clinical trial · Interventional
A Study of Telemonitoring in Cancer Patients
A Study of the Benefit of Telemonitoring for Hospital Staff Treating Patients With Oral or Intravenous Cancer Treatments: a French Prospective, Randomized, Unblinded, Single-centre Study.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this prospective, randomized, unblinded, single-centre, interventional study is to assess the effectiveness of standard of care with Cureety, compared to standard of care alone, to reduce the number of all telephone calls during the first 4 months of oral or intravenous cancer treatment for patients older than 18 years of age, initiating oral or intravenous cancer treatment at the Centre Hospitalier de Bligny. Patients initiating either oral or intravenous chemotherapy for cancer will be randomly allocated in a 1:1 ratio to either: * In-person care alone (Standard of care group). * In-person care with Cureety telemonitoring (Standard of care with Cureety group). Participants will: * be monitored with digital application Cureety (Standard of care with Cureety group) * fill out quality of life questionnaire (baseline, 2 months, 4 months) * fill out satisfaction questionnaire (2 months, 4 months) * have the ongoing and incoming phone calls logged (duration and type)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| remote patient monitoring | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Standard of care group
- description
- Standard of care
- type
- EXPERIMENTAL
- label
- Standard of care with Cureety group
- description
- In-person care with remote patient monitoring with the Cureety application
- interventionNames
- Device: remote patient monitoring
Primary outcomes (1)
- measure
- Number of all telephone calls during the first 4 months of oral or intravenous cancer treatment
- timeFrame
- 4 months after randomization
- description
- Number of calls, defined as the number of incoming and outgoing calls that occurs during the 4 months from randomization
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients that have provide written informed consent for study participation. 2. Patients aged 18 years or older. 3. Patients initiating oral or intravenous treatment (chemotherapy, immunotherapy, targeted therapies etc.) for localized or metastatic or recurrent cancer treated at the CH Bligny. 4. Patients with the capacity, personally (e.g., language and capacity to use the application), and in terms of infrastructure (internet access, possessing a smart phone etc.) to perform telemonitoring with Cureety. 5. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2 Exclusion Criteria: * Patients treated for cancer at the CH Bligny in the last 5 years
References
Publications (0)
Data not yet available